Skip to Main Content
Back to News

SEC's New Era for SPACs: Tightening Rules Amid Market Realities

Quiver Quantitative Logo

In a significant shift, the US Securities and Exchange Commission (SEC) is implementing new rules to tighten the reins on Special Purpose Acquisition Companies (SPACs), a move set to challenge the previously unbridled optimism surrounding these entities. At the height of the SPAC boom, startups enjoyed the liberty of promoting ambitious future goals with minimal legal repercussions. However, the reality post-merger has often been starkly different, as seen in the cases of Hyzon Motors (HYZN) and MSP Recovery (MSPR), whose actual performances have fallen significantly short of their initial projections.

This regulatory tightening comes as many companies that merged with SPACs during the pandemic era face the consequences of their overzealous forecasts. The new SEC rules, expected to come into force later this year, will remove the legal protections previously afforded to SPACs, holding them to stricter disclosure standards. This change marks the beginning of a new era for SPACs, with increased liability and a more stringent regulatory environment. As Shivani Poddar, a litigation partner at Herrick, Feinstein LLP, notes, these rules represent the first step in the SEC's clampdown on SPACs, shifting the liability landscape for all parties involved.

Market Overview:
-Overly optimistic forecasts that fueled the SPAC boom come under SEC scrutiny, exposing performance shortfalls and sparking investor ire.
-New rules tighten disclosure requirements, raising legal risks for prospective issuers and ushering in a stricter era for blank-check companies.
-Companies like Hyzon Motors and MSP Recovery highlight the perils of inflated expectations, with results falling far short of pre-SPAC promises.

Key Points:
-SEC aims to protect investors from misleading forecasts by removing legal shields for SPACs under new regulatory framework.
-Nearly half of former SPACs languish below $2 per share, struggling with weak financials and facing potential cash crunches.
-Nikola's production woes and TMC's 25-year Ebitda projections exemplify the audacity, and potential pitfalls, of some SPAC forecasts.
-While DraftKings and MoonLake Immunotherapeutics offer success stories, the majority grapple with reality checks, eroding investor confidence.

Looking Ahead:
-Stricter disclosure requirements and increased legal liability paint a challenging landscape for future SPAC activity.
-Performance pressure intensifies for de-SPACs navigating economic headwinds and investor wariness of speculative ventures.
-The SEC's move marks a potential turning point, pushing SPACs towards greater accountability and a focus on realistic growth prospects.

The move aims to extend investor protections to alternative public listing methods. The SEC's initiative is particularly important for less sophisticated investors, like those who fueled the meme stock craze, who may not fully grasp the uncertainties inherent in company forecasts made before a SPAC merger. The new rules mean firms involved in deals could face increased legal threats, potentially adding to the chill in an already cooling market. The impact is already visible in the sharp decline in SPAC IPOs since 2021 and the struggles of many companies that used SPAC mergers for back-door entries onto major US exchanges.

Despite the dismal performance of many former SPACs, with nearly 200 trading below $2 per share, the market has seen some success stories. For instance, DraftKings (DKNG), which went public in 2020, has seen its shares nearly quadruple. This mixed bag of outcomes highlights the complexities of SPAC transactions and underscores the need for a balanced approach that acknowledges both the potential benefits and risks of this alternative route to going public.

About the Author

David Love is an editor at Quiver Quantitative, with a focus on global markets and breaking news. Prior to joining Quiver, David was the CEO of Winter Haven Capital.

Suggested Articles